Evaluation of Epigenetic and Radiomodifying Effects during Radiotherapy Treatments in Zebrafish

Int J Mol Sci. 2021 Aug 22;22(16):9053. doi: 10.3390/ijms22169053.

Abstract

Radiotherapy is still a long way from personalizing cancer treatment plans, and its effectiveness depends on the radiosensitivity of tumor cells. Indeed, therapies that are efficient and successful for some patients may be relatively ineffective for others. Based on this, radiobiological research is focusing on the ability of some reagents to make cancer cells more responsive to ionizing radiation, as well as to protect the surrounding healthy tissues from possible side effects. In this scenario, zebrafish emerged as an effective model system to test for radiation modifiers that can potentially be used for radiotherapeutic purposes in humans. The adoption of this experimental organism is fully justified and supported by the high similarity between fish and humans in both their genome sequences and the effects provoked in them by ionizing radiation. This review aims to provide the literature state of the art of zebrafish in vivo model for radiobiological studies, particularly focusing on the epigenetic and radiomodifying effects produced during fish embryos' and larvae's exposure to radiotherapy treatments.

Keywords: embryogenesis; epigenetics; radiomodifiers; radiotherapy; zebrafish.

Publication types

  • Review

MeSH terms

  • Animals
  • Embryo, Nonmammalian / drug effects
  • Embryo, Nonmammalian / radiation effects
  • Embryonic Development / drug effects
  • Embryonic Development / radiation effects
  • Epigenesis, Genetic / radiation effects*
  • Models, Animal
  • Radiation-Sensitizing Agents / adverse effects*
  • Radiotherapy / adverse effects*
  • Zebrafish*

Substances

  • Radiation-Sensitizing Agents